Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194346 | SCV000246369 | benign | not specified | 2019-01-16 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000194346 | SCV000856283 | likely benign | not specified | 2017-08-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000959107 | SCV001105996 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000959107 | SCV001500911 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | ANK3: BP4, BS2 |
Breakthrough Genomics, |
RCV000959107 | SCV005220799 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004530092 | SCV004734141 | benign | ANK3-related disorder | 2021-09-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |